Status: Not yet recruiting
Dietary Supplement for Telogen Effluvium Associated With GLP-1 Receptor Agonist Use
A single-center, open-label clinical study to evaluate whether a dietary supplement can reduce hair loss in women with GLP-1-associated telogen effluvium. Participants will use the supplement for 120 days. Researchers will evaluate hair loss, hair density, and hair growth through clinical assessments, hair measurements (trichogram), and participant questionnaires.
Participants needed: 48
Trial details
Age: 20-60Biological sex: FemaleType: InterventionalSponsor: Farmoquimica S.A.Updated: Aug 27, 2026Locations: 1
Eligibility criteria
Female participants aged 20 to 60 years. [+11]
Pregnancy, breastfeeding, postpartum period up to 6 months, or intention to beco... [+24]